
Higher Stroke Risk Decades After Adverse Pregnancy Outcomes
A significant risk for stroke was found up to 46 years after delivery in a third of women who'd had any of five adverse pregnancy outcomes, according to a large national cohort study.
An international team of investigators discovered that compared with women who'd had no adverse pregnancy outcomes, those who'd experienced preterm delivery, delivery of an infant small for gestational age, preeclampsia, other hypertensive disorders, or gestational diabetes, still faced a 1.2- to 2.5-fold greater risk for stroke anywhere from 30 to 46 years after delivery.
The results were published in the European Heart Journal .
'Women with adverse pregnancy outcomes need early preventive actions and long-term follow-up to reduce their lifelong risk of stroke,' wrote the investigators led by Casey Crump, MD, PhD, MS, MPH, an epidemiologist in the Departments of Family and Community Medicine and Epidemiology, The University of Texas Health Science Center, Houston.
About a third of all women in their reproductive years experience an adverse pregnancy outcome, according to experts. Meanwhile, stroke is the third leading cause of death worldwide, with women bearing the brunt of the disease.
To determine which adverse pregnancy outcomes are associated with the highest risk for stroke in women, Crump and his co-investigators examined data on 2,201,393 women who gave birth to a singleton between 1973 and 2015 in Sweden.
The cohort was followed up for stroke through 2018. Cox regression was used to determine hazard ratios (HRs) for stroke associated with each of the five adverse outcomes and was adjusted for other maternal factors such as age, BMI, and smoking history.
Crump and colleagues found that in 48 million person-years of follow-up, 667,774 (30%) women experienced an adverse pregnancy outcome and 35,824 (1.6%) women were diagnosed with any form of stroke, including ischemic or hemorrhagic stroke with all its major subtypes such as intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage.
All five adverse pregnancy outcomes were independently associated with long-term increased risks of stroke. With up to 46 years of follow-up, the highest adjusted HR for stroke was associated with gestational diabetes at 1.86 (95% CI, 1.69-2.04).
For hypertensive disorders other than preeclampsia, the HR was 1.82 (95% CI, 1.67-1.98). For preterm delivery it was 1.40 (95% CI, 1.36-1.45) and for preeclampsia, the HR was 1.36 (95% CI, 1.31-1.41). In deliveries with the infant being small for gestational age, the HR was 1.26 (95% CI, 1.22-1.29). All HRs remained significantly elevated (1.2- to 2.5-fold) even 30-46 years after delivery.
The adjusted HRs for associated stroke were highest in the first 10 years after delivery in hypertensive disorders other than preeclampsia, preterm delivery, and small for gestational age. However, the adjusted HRs associated with gestational diabetes, largely mediated by type 2 diabetes, increased with additional follow-up time between 30 and 46 years (2.51; 95% CI 2.15-2.93).
Genetics and common familial factors only partially explained the stroke risks. The investigators conducted co-sibling analyses for potential confounding by shared genetic or environmental factors such as air pollution or passive smoking in 1,191,316 (54%) women in the cohort who had at least one full sister who also had a singleton delivery, regardless of adverse outcome status.
Psychological factors could also be at play in the sustained elevated stroke risk, according to Abbi D. Lane, PhD, an assistant professor of applied exercise science at the University of Michigan School of Kinesiology, Ann Arbor, Michigan, who wrote an editorial accompanying the study.
'Not only does the complicated pregnancy/birth itself cause stress, but the psychological and/or medical sequelae of the adverse pregnancy outcome can last for months or years,' Lane wrote.
Referencing the 2017 INTERSTROKE Study of population level risks for stroke, Lane noted that the population-attributable risk associated in women with psychosocial stress (15.0%; 95% CI 8.5%-25.2%), which was measured using questions about work and home stress, life events, and depression, was similar to that associated with poor diet (22.9%; 95% CI 15.3%-32.7%), cardiac causes (11.1%; 95% CI 9.4%-12.9%), and smoking (5.3%; 95% CI% 3.7%-7.6%).
'Babies born after an adverse pregnancy outcome are more likely to be admitted to the neonatal intensive care unit,' she wrote. '[They] are more likely to have short- or longer- term medical complications and to be diagnosed with neurodevelopmental disorders. Managing medical and neurodevelopmental disorders can lead to months or years of emotional, logistical, and financial strain for parents.'
The INTERSTROKE study's finding that strokes are 90% preventable, plus this study's finding that a third of women with adverse pregnancy outcomes have an elevated risk for stroke, requires preemptive action, according to Lane. 'Delivery methods for any postpartum intervention could include home-based or virtual sessions to reduce child care or travel burden, and improve feasibility,' she wrote.
Another expert said the study also provides opportunities for treating patients at risk for stroke.
'This study adds to our clinical practice by emphasizing the need to acknowledge sex-specific risk factors and their impact on stroke risk while actively improving their current modifiable risk factors with individualized care,' Lily Dastmalchi, DO, told Medscape Medical News . Dastmalchi is a cardiologist at the Inova Health System in greater Washington, DC.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
NATO fund backs biotech startup in push to counter biological threats
By Supantha Mukherjee STOCKHOLM (Reuters) -The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance defences against biological threats The fund is co-leading a $35 million fundraising round for Portal Biotech, which uses protein sequencing to detect engineered threats and defend against biological warfare. UK-based Portal Biotech's capability is essential for biosecurity defence and security, said Ana Bernardo-Gancedo, senior associate at NATO Innovation Fund. "We believe that it is absolutely imperative that we are able to detect, monitor and create countermeasures," she said. The fund, created in 2022 after the Russian invasion of Ukraine, plans to invest more than $1 billion in technologies that would enhance NATO's defences. Portal Biotech uses an AI-backed technology with biological sensors that can work at the single molecule level on-site, giving results within hours. "It's for everything from measuring diseases to better pandemic prevention ... you can take this out of large labs with long turnaround times and into the field," CEO Andy Heron told Reuters. Heron said the company's instruments can detect any pathogen and can be used for continuous monitoring of anything from a field to water supply. "It allows you not just to detect what you did know was out there, but it allows you to detect what you didn't know," he said. Beyond biosecurity, Portal Biotech expects its portable equipment to aid in drug discovery and precision medicine. The company's investors include Earlybird Venture Capital, Science Creates VC, Pillar VC, 8VC, We VC and British Business Bank. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Medscape
an hour ago
- Medscape
Respiratory Training Shows Modest Benefits in ALS
TOPLINE: Respiratory muscle training moderately improved lung function, especially respiratory muscle strength, in patients with amyotrophic lateral sclerosis (ALS) compared with no intervention or sham training. METHODOLOGY: Researchers conducted a meta-analysis to assess the effect of respiratory muscle training on lung function and respiratory muscle strength in patients with ALS. They gathered data from five randomized controlled trials including 170 patients with ALS (mean age range, 53-63 years; 58.8%-69.2% men), majority of whom had spinal onset of the disease (72.9%-84.6%). Researchers assessed the role of standalone respiratory muscle training and compared it with control conditions — physical exercise, usual care, or no intervention — to gauge its unique impact. The outcomes included assessments of lung function, respiratory muscle strength, survival, functional capacity, and adverse events. TAKEAWAY: According to a meta-analysis of three trials, maximum expiratory pressure was superior in the group that underwent respiratory muscle training compared with control conditions (standardized mean difference [SMD], 19.53; P = .02). Similarly, respiratory muscle training significantly improved the maximum inspiratory pressure compared with control conditions (SMD, 13.96; P = .010). A meta-analysis of four trials found no significant difference in the forced vital capacity between the groups (SMD, 0.90; P = .14). No studies reported serious adverse effects, supporting respiratory muscle training as a safe intervention for patients with ALS. IN PRACTICE: 'RMT [respiratory muscle training] shows potential as an adjuvant intervention for patients with ALS,' the authors wrote. SOURCE: This study was led by María Jesús Benzo-Iglesias, Health Research Centre, Humanidades-498 Research Group, University of Almería, Almería, Spain. It was published online on June 09, 2025, in Therapeutic Advances in Respiratory Disease. LIMITATIONS: This study had a small sample size, which limited the generalizability of the findings. It comprised only five trials, which may have affected the findings' robustness and restricted the ability to perform sensitivity analyses. The wide CIs in the heterogeneity analysis indicated substantial heterogeneity. DISCLOSURES: This study did not receive any funding. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Bloomberg
an hour ago
- Bloomberg
Talc Isn't Just in Baby Powder. It's Also in Vitamins and Drugs
Hey there, it's Anna in Virginia. I recently learned about a startling ingredient in many popular vitamins and drugs, but before we get to that ... Multivitamins, cholesterol drugs, antibiotics. Besides aiming to make us healthier, these capsules and tablets have another thing in common: some of them contain talc.